1973BMJOpen access

Comparative Trial of a New Anticholinergic Bronchodilator, Sch 1000, and Salbutamol in Chronic Bronchitis

H Poppius, Yrjö Salorinne

Open full text 85 citations

Abstract

In 20 patients with chronic bronchitis and moderate or severe airways obstruction inhalation of 40 mug of a new anticholinergic drug, Sch 1000, was found to produce stronger and more persistent bronchodilation than inhalation of 200 mug of salbutamol.

Open-access reader

About this research paper

What this paper is about

In 20 patients with chronic bronchitis and moderate or severe airways obstruction inhalation of 40 mug of a new anticholinergic drug, Sch 1000, was found to produce stronger and more persistent bronchodilation than inhalation of 200 mug of salbutamol.

Why it matters

OpenAlex reports 85 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In 20 patients with chronic bronchitis and moderate or severe airways obstruction inhalation of 40 mug of a new anticholinergic drug, Sch 1000, was found to produce stronger and more persistent bronchodilation than inhalation of 200 mug of salbutamol.

Key concepts: Salbutamol, Bronchodilation, Anticholinergic, Bronchodilator, Medicine, Chronic bronchitis, Inhalation, Bronchitis

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparative Trial of a New Anticholinergic Bronchodilator, Sch 1000, and Salbutamol in Chronic Bronchitis — Research Paper | ScholarLens